PLX SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0002086358-26-000006
PLX filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 15, 2026. A Schedule 13G was filed regarding beneficial ownership of Protalix BioTherapeutics, Inc. (PLX). The stock moved +3.4% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding beneficial ownership of Protalix BioTherapeutics, Inc. (PLX). The filing indicates a passive investor holds a stake in the company, though specific ownership details are not disclosed in the available filing text.
Key details
How PLX stock reacted
Close before
$2.61
Oct 14, 2026
First close after
+3.45%
$2.70
5 trading days
-1.53%
$2.57
Since filing
-1.15%
$2.58
✦ Ask GOAX AI about this filing — what it means for PLX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PLX?
Click hereFrequently asked questions
What did PLX file with the SEC on Oct 15, 2026?
PLX filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding beneficial ownership of Protalix BioTherapeutics, Inc. (PLX). The filing indicates a passive investor holds a stake in the company, though specific ownership details are not disclosed in the available filing text.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did PLX stock react to this filing?
PLX closed at $2.61 before the filing and $2.70 on Oct 15, 2026 (+3.45%). Five trading days later: $2.57 (-1.53%).
Other PLX SEC filings
Get alerts when PLX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days